Ryan Specialty (NYSE:RYAN – Get Free Report) will likely be posting its Q4 2025 results after the market closes on Thursday, February 12th. Analysts expect Ryan Specialty to post earnings of $0.50 per share and revenue of $777.4260 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 12, 2026 at 5:00 PM ET.
Ryan Specialty Trading Up 1.4%
Shares of NYSE:RYAN opened at $47.62 on Thursday. Ryan Specialty has a 52-week low of $46.18 and a 52-week high of $77.16. The company has a debt-to-equity ratio of 2.72, a quick ratio of 1.00 and a current ratio of 1.00. The company has a market capitalization of $12.56 billion, a P/E ratio of 103.52, a price-to-earnings-growth ratio of 1.19 and a beta of 0.62. The company has a 50-day simple moving average of $51.96 and a 200 day simple moving average of $54.97.
Insider Activity at Ryan Specialty
In related news, CEO Timothy William Turner sold 129,570 shares of the firm’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $53.61, for a total transaction of $6,946,247.70. Following the transaction, the chief executive officer directly owned 12,553 shares of the company’s stock, valued at approximately $672,966.33. This trade represents a 91.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 52.21% of the company’s stock.
Institutional Investors Weigh In On Ryan Specialty
Wall Street Analysts Forecast Growth
RYAN has been the subject of several research analyst reports. UBS Group reduced their target price on Ryan Specialty from $80.00 to $75.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Wells Fargo & Company lifted their price objective on shares of Ryan Specialty from $61.00 to $63.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 13th. TD Cowen reiterated a “buy” rating on shares of Ryan Specialty in a report on Wednesday, November 26th. BMO Capital Markets cut their target price on shares of Ryan Specialty from $70.00 to $66.00 and set an “outperform” rating for the company in a research note on Monday, November 3rd. Finally, Morgan Stanley set a $61.00 price target on shares of Ryan Specialty in a research note on Tuesday, December 16th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $64.19.
View Our Latest Stock Report on RYAN
About Ryan Specialty
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Featured Stories
- Five stocks we like better than Ryan Specialty
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- New gold price target
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
